Crucial pathway alterations contribute to bioenergetic profile dysregulation in human melanoma, including B-Raf proto-oncogene serine/threonine-protein kinase (BRAF) mutations, neuroblastoma RAS viral oncogene protein (NRAS) overexpression, or deletion of PTEN [28], among others. The gene discussed is NRAS; the disease is melanoma.